Literature DB >> 8012195

Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy.

G Piccolo1, G Azan, P Tonin, E Arbustini, A Gavazzi, P Banfi, M Mora, L Morandi, S Tedeschi.   

Abstract

A neurologically asymptomatic 32-yr-old man recently transplanted for end-stage dilated cardiomyopathy presented with progressively increasing serum creatine kinase level (hyperCKemia) while receiving cyclosporin and simvastatine treatment. Revised family history led to suspicion of X-linked inherited myopathy, then confirmed by muscle biopsy findings showing myopathic dystrophic changes, a patchy distribution of immunoreactivity on the sarcolemma of several muscle fibres with anti-dystrophin antibodies and a double dystrophin band of normal and lower molecular weight on immunoblot analysis. A molecular genetic study demonstrated a deletion spanning over exons 45-47 at Xp21 locus. Routine neurological evaluation and currently available laboratory investigation may lead to early diagnosis of otherwise unrecognized Xp21 BMD among patients presenting with dilated cardiomyopathy alone, thus avoiding subsequent diagnostic difficulties.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012195     DOI: 10.1016/0960-8966(94)90006-x

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

1.  Effect of adopting a new histological grading system of acute rejection after heart transplantation.

Authors:  A H Balk; P E Zondervan; P van der Meer; T van Gelder; B Mochtar; M L Simoons; W Weimar
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

Review 2.  Dilated cardiomyopathy.

Authors:  Neal K Lakdawala; Jeffery R Winterfield; Birgit H Funke
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-09-28

3.  Cardiac-Specific Expression of ΔH2-R15 Mini-Dystrophin Normalized All Electrocardiogram Abnormalities and the End-Diastolic Volume in a 23-Month-Old Mouse Model of Duchenne Dilated Cardiomyopathy.

Authors:  Nalinda B Wasala; Jin-Hong Shin; Yi Lai; Yongping Yue; Federica Montanaro; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2018-03-22       Impact factor: 5.695

4.  Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.

Authors:  E L Hanson; R E Hershberger
Journal:  J Genet Couns       Date:  2001-10       Impact factor: 2.537

Review 5.  Investigation of muscle disease.

Authors:  F L Mastaglia; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

Review 6.  Dilated cardiomyopathy as the initial presentation of Becker muscular dystrophy: a systematic review of published cases.

Authors:  Gaspar Del Rio-Pertuz; Cristina Morataya; Kanak Parmar; Sarah Dubay; Erwin Argueta-Sosa
Journal:  Orphanet J Rare Dis       Date:  2022-05-12       Impact factor: 4.303

7.  Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.

Authors:  Ju Lan Chun; Robert O'Brien; Min Ho Song; Blake F Wondrasch; Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2012-12-27       Impact factor: 6.940

Review 8.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

Review 9.  X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy.

Authors:  Akinori Nakamura
Journal:  Pharmaceuticals (Basel)       Date:  2015-06-09

10.  X-Linked Dilated Cardiomyopathy Presenting as Acute Rhabdomyolysis and Presumed Epstein-Barr Virus-Induced Viral Myocarditis: A Case Report.

Authors:  Jacques A J Malherbe; Sue Davel
Journal:  Am J Case Rep       Date:  2018-06-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.